Back to 2015 Annual Meeting Posters
Palliative management of malignant pleural effusions due to mesothelioma using PleuRx® drains.
Rizwan Attia, Farhana Akter, Loic Lang-Lazdunski.
Guy's and St Thomas NHS foundation Trust, London, United Kingdom.
OBJECTIVE: Mesothelioma malignant pleural effusions (MMPEs) have a poor prognosis and are associated with a high morbidity. Thoracentesis may be quick and relatively easy to perform, but has a high recurrence rate; chest tube placement with talc slurry is quite effective at achieving pleurodesis, but this procedure can be quite painful and requires hospitalization with consequent reduction in mobility and lead to poor quality of life. An alternative option is placement of the Pleurx® catheter (Denver Biomedical Inc., Denver, CO) for home-based drainage of effusions.
Pleurx® catheter drains have been used in lung cancer effusions there is no published data in mesothelioma. We aimed to determine the effectiveness of Pleurx drain management of malignant mesothelioma effusion (MME) in reducing hospital stay, hospital readmissions due to effusions and radiological effectiveness in lung expansion.
METHODS: We analyzed all patients that underwent Pleurx drain insertion for MMPE over a 7-year period under a single surgeon.
RESULTS: 53 patients (12M: 1F) mean age 71 (48-87), had Pleurx inserted for a mean duration of 60 days (epitheliod (50%), sarcomatoid (22%) and biphasic (28%)). There were no immediate drain related complications, whilst two patients needed readmission for exchange of pleurx drain for a blockage. Median post-operative hospital stay was 2-days. There were no hospital readmissions for effusion related dysponea. Patients were followed till death. Median duration of Pleurx insertion to death was 13.8±1.95 months. There were admissions related to other mesothelioma related complications (1 for SVC obstruction and 2 for palliation of pain). Immediate radiological improvement with lung inflation to >50% on comparison to pre-operative radiographs was achieved in 30/50 (60%) patients, 37/50(74%) at 2 weeks post insertion.
CONCLUSIONS: Pleurx drainage provides effective treatment for palliation of MMPEs with minimal hospital stay, no hospital readmission and radiological improvement in lung inflation. It should be considered as a viable treatment option in palliation of mesothelioma patients.
Back to 2015 Annual Meeting Posters




